The Role of Indoleamine-2,3-Dioxygenase in Cancer Development, Diagnostics, and Therapy
出版年份 2018 全文链接
标题
The Role of Indoleamine-2,3-Dioxygenase in Cancer Development, Diagnostics, and Therapy
作者
关键词
-
出版物
Frontiers in Immunology
Volume 9, Issue -, Pages -
出版商
Frontiers Media SA
发表日期
2018-01-31
DOI
10.3389/fimmu.2018.00151
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- The rationale of indoleamine 2,3-dioxygenase inhibition for cancer therapy
- (2017) Lieve Brochez et al. EUROPEAN JOURNAL OF CANCER
- A Relay Pathway between Arginine and Tryptophan Metabolism Confers Immunosuppressive Properties on Dendritic Cells
- (2017) Giada Mondanelli et al. IMMUNITY
- A subcellular map of the human proteome
- (2017) Peter J. Thul et al. SCIENCE
- Nanomedicine and cancer immunotherapy: focus on indoleamine 2,3-dioxygenase inhibitors
- (2017) Bilal Zulfiqar et al. OncoTargets and Therapy
- Blockade of IDO-kynurenine-AhR metabolic circuitry abrogates IFN-γ-induced immunologic dormancy of tumor-repopulating cells
- (2017) Yuying Liu et al. Nature Communications
- Constitutive IDO1 Expression in Human Tumors Is Driven by Cyclooxygenase-2 and Mediates Intrinsic Immune Resistance
- (2017) Marc Hennequart et al. Cancer Immunology Research
- Cervical Cancer Neoantigen Landscape and Immune Activity is Associated with Human Papillomavirus Master Regulators
- (2017) Yong Qin et al. Frontiers in Immunology
- Preclinical efficacy of immune-checkpoint monotherapy does not recapitulate corresponding biomarkers-based clinical predictions in glioblastoma
- (2017) Abhishek D. Garg et al. OncoImmunology
- Analysis of Kynurenine/Tryptophan ratio and expression of IDO1 and 2 mRNA in tumour tissue of cervical cancer patients
- (2016) Jayakumar Hascitha et al. CLINICAL BIOCHEMISTRY
- In vitro cytokine licensing induces persistent permissive chromatin at the Indoleamine 2,3-dioxygenase promoter
- (2016) Yazmin I. Rovira Gonzalez et al. CYTOTHERAPY
- Distinct roles of immunoreceptor tyrosine-based motifs in immunosuppressive indoleamine 2,3-dioxygenase 1
- (2016) Elisa Albini et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- Tolerogenic Phenotype of IFN-γ–Induced IDO+Dendritic Cells Is Maintained via an Autocrine IDO–Kynurenine/AhR–IDO Loop
- (2016) Qingsheng Li et al. JOURNAL OF IMMUNOLOGY
- Improved Radiosynthesis and Biological Evaluations of L- and D-1-[18F]Fluoroethyl-Tryptophan for PET Imaging of IDO-Mediated Kynurenine Pathway of Tryptophan Metabolism
- (2016) Yangchun Xin et al. MOLECULAR IMAGING AND BIOLOGY
- Fully automated radiosynthesis of N1-[18F]fluoroethyl-tryptophan and study of its biological activity as a new potential substrate for indoleamine 2,3-dioxygenase PET imaging
- (2016) Jean Henrottin et al. NUCLEAR MEDICINE AND BIOLOGY
- GTRD: a database of transcription factor binding sites identified by ChIP-seq experiments
- (2016) Ivan Yevshin et al. NUCLEIC ACIDS RESEARCH
- IDO in the Tumor Microenvironment: Inflammation, Counter-Regulation, and Tolerance
- (2016) David H. Munn et al. TRENDS IN IMMUNOLOGY
- Suppressive role of myeloid-derived suppressor cells (MDSCs) in the microenvironment of breast cancer and targeted immunotherapies
- (2016) Dawei Shou et al. Oncotarget
- Molecular Pathways: Targeting IDO1 and Other Tryptophan Dioxygenases for Cancer Immunotherapy
- (2015) L. Zhai et al. CLINICAL CANCER RESEARCH
- The tryptophan metabolite picolinic acid suppresses proliferation and metabolic activity of CD4+ T cells and inhibits c-Myc activation
- (2015) Johanna Prodinger et al. JOURNAL OF LEUKOCYTE BIOLOGY
- Chromatin architecture reorganization during stem cell differentiation
- (2015) Jesse R. Dixon et al. NATURE
- IL-27 induces the expression of IDO and PD-L1 in human cancer cells
- (2015) Grazia Carbotti et al. Oncotarget
- Understanding the role of the kynurenine pathway in human breast cancer immunobiology
- (2015) Benjamin Heng et al. Oncotarget
- Tumor-Expressed IDO Recruits and Activates MDSCs in a Treg-Dependent Manner
- (2015) Rikke B. Holmgaard et al. Cell Reports
- Tryptophan-Degrading Enzymes in Tumoral Immune Resistance
- (2015) Nicolas van Baren et al. Frontiers in Immunology
- New Insights into IDO Biology in Bacterial and Viral Infections
- (2014) Susanne V. Schmidt et al. Frontiers in Immunology
- AhR-Mediated, Non-Genomic Modulation of IDO1 Function
- (2014) Maria Teresa Pallotta et al. Frontiers in Immunology
- Trial watch: IDO inhibitors in cancer therapy
- (2014) Erika Vacchelli et al. OncoImmunology
- Therapeutic gene modified cell based cancer vaccines
- (2013) Anna Kozłowska et al. GENE
- Aryl hydrocarbon receptor signaling regulates NF-κB RelB activation during dendritic-cell differentiation
- (2013) Christoph F A Vogel et al. IMMUNOLOGY AND CELL BIOLOGY
- Regulation of IDO Activity by Oxygen Supply: Inhibitory Effects on Antimicrobial and Immunoregulatory Functions
- (2013) Silvia K. Schmidt et al. PLoS One
- A road less traveled paved by IDO silencing
- (2013) Edwin R. Manuel et al. OncoImmunology
- Systemic Delivery of Salmonella typhimurium Transformed with IDO shRNA Enhances Intratumoral Vector Colonization and Suppresses Tumor Growth
- (2012) C. A. Blache et al. CANCER RESEARCH
- Unknown
- (2012) Ciriana Orabona et al. MOLECULAR MEDICINE
- Indoleamine 2,3 dioxygenase and metabolic control of immune responses
- (2012) David H. Munn et al. TRENDS IN IMMUNOLOGY
- How melanoma cells inactivate NK cells
- (2012) Gabriella Pietra et al. OncoImmunology
- Indoleamine 2,3-Dioxygenase Expression in Human Cancers: Clinical and Immunologic Perspectives
- (2011) J. Godin-Ethier et al. CLINICAL CANCER RESEARCH
- Indoleamine-2,3-dioxygenase, an immunosuppressive enzyme that inhibits natural killer cell function, as a useful target for ovarian cancer therapy
- (2011) DONGDONG WANG et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- Activated CD69+ T Cells Foster Immune Privilege by Regulating IDO Expression in Tumor-Associated Macrophages
- (2011) Q. Zhao et al. JOURNAL OF IMMUNOLOGY
- Hypoxia regulates the production and activity of glucose transporter-1 and indoleamine 2,3-dioxygenase in monocyte-derived endothelial-like cells: possible relevance to infantile haemangioma pathogenesis
- (2010) A. Herbert et al. BRITISH JOURNAL OF DERMATOLOGY
- T-Cell Activation under Hypoxic Conditions Enhances IFN-γ Secretion
- (2009) Jessica Roman et al. AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY
- TGF-β and kynurenines as the key to infectious tolerance
- (2009) Maria L. Belladonna et al. TRENDS IN MOLECULAR MEDICINE
- Adenosine receptors in regulation of dendritic cell differentiation and function
- (2008) S. V. Novitskiy et al. BLOOD
- IDO1 and IDO2 are expressed in human tumors: levo- but not dextro-1-methyl tryptophan inhibits tryptophan catabolism
- (2008) Stefan Löb et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Indoleamine 2,3-dioxygenase in T-cell tolerance and tumoral immune escape
- (2008) Jessica B. Katz et al. IMMUNOLOGICAL REVIEWS
- Co-operative action of interleukin-10 and interferon-γ to regulate dendritic cell functions
- (2008) Yoshiki Yanagawa et al. IMMUNOLOGY
- SOCS3 drives proteasomal degradation of indoleamine 2,3-dioxygenase (IDO) and antagonizes IDO-dependent tolerogenesis
- (2008) C. Orabona et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started